20 hrs ago
LabCorp Updates 2013 Guidance and Provides Preliminary 2014 Guidance
Laboratory Corporation of America Holdings today reaffirmed its prior revenue growth guidance of approximately 3% and updated its non-GAAP full year 2013 Adjusted Earnings Per Share Excluding Amortization guidance to between $6.90 and $7.05.
LabCorp Announces the Availability of Hepatitis C Virus Q80k...
Q80K is a naturally occurring polymorphism that develops in certain strains of HCV, making the virus less susceptible to Janssen Therapeutics' OLYSIOa , which was recently approved by the U.S. Food and Drug Administration for the treatment of certain adult patients diagnosed with genotype 1chronic hepatitis C .
Customer Interaction Solutions
RainDance Technologies Names Alfred G. Merriweather Chief Financial Officer
RainDance Technologies, Inc., a genomics tools company enabling development of ultra-sensitive and non-invasive methods for early detection of cancer and inherited diseases, today announced that Alfred G. Merriweather has joined the company as Chief Financial Officer.
LabCorp Announces the Availability of a 4th Generation HIV Assay to...
LabCorp Announces the Availability of a 4 th Generation HIV Assay to Allow the Earlier Detection of Acute HIV Infection )--Laboratory Corporation of AmericaA Holdings announced today the availability of a 4th generation HIV antigen/antibody combination assay and a new diagnostic algorithm that improves screening for HIV infection.